CDR-Life is a biotherapeutics company developing novel therapies harnessing the power of the immune system. Today’s cancer immunotherapies are powerful but are not tumor targeted, which compromises both efficacy and safety. We are developing a next generation of highly tumor-selective immunotherapies to truly empower the immune system to eradicate malignant cells without the off-tumor-related limitations of current immunotherapies. CDR-Life has developed the unique M-gager® technology to generate MHC-specific antibody-based T cell engagers that target highly tumor-specific intracellular antigens with unparalleled specificity. Our dual-MHC binding molecule format based on antibody fragments has the promise of developing new immunotherapies with high tumor cell killing potency, longer duration of effect, and lower risk of immune-related adverse effects. CDR-Life is advancing a growing portfolio of novel and highly tumor-selective immunotherapies based on the M-gager® technology.
View Top Employees from CDR-Life Inc.Website | https://www.cdr-life.com |
Revenue | $5 million |
Employees | 66 (49 on RocketReach) |
Founded | 2017 |
Address | Wagistrasse 27, Schlieren, Zurich 8952, CH |
Phone | +41 44 515 98 98 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Antibody fragments, Healthcare, Science and Engineering, Biologics development, Ophthalmology |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular CDR-Life Inc. employee's phone or email?
The CDR-Life Inc. annual revenue was $5 million in 2024.
Konstantin von Schulthess is the CFO of CDR-Life Inc..
49 people are employed at CDR-Life Inc..
CDR-Life Inc. is based in Schlieren, Zurich.
The NAICS codes for CDR-Life Inc. are [54, 541713, 5417, 54171, 541].
The SIC codes for CDR-Life Inc. are [87, 873].